Bacillus coitalence MTCC 5856 for the management of major depressive disorder

摘要

The present invention discloses the use of probiotics for the therapeutic management of major depressive disorders (MDD). More specifically, the present invention provides probiotic strains Bacillus in a mammal with irritable bowel syndrome It discloses a method for managing the MDD therapeutically by using the core tangerine balancing MTCC 5856.